Clínica Universitaria de Navarra -ko ikertzaileekin lankidetzan egindako argitalpenak (60)

2022

  1. A holistic approach to evaluating Parkinson's disease, using the Delphi method: a linear evaluation index

    Arquivos de Neuro-Psiquiatria, Vol. 80, Núm. 2, pp. 145-152

  2. Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy

    Translational Neurodegeneration, Vol. 11, Núm. 1

  3. Trial of Prasinezumab in Early-Stage Parkinson's Disease

    New England Journal of Medicine, Vol. 387, Núm. 5, pp. 421-432

2021

  1. Blood pressure and risk of cognitive impairment: The role of vascular disease in neurodegeneration

    Brain Sciences, Vol. 11, Núm. 3

  2. Microglia is associated with p-Tau aggregates in the olfactory bulb of patients with neurodegenerative diseases

    Neurological Sciences, Vol. 42, Núm. 4, pp. 1473-1482

  3. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein

    Acta Neuropathologica Communications, Vol. 9, Núm. 1

2019

  1. Amylin as a potential link between type 2 diabetes and alzheimer disease

    Annals of Neurology, Vol. 86, Núm. 4, pp. 539-551

  2. Cardiac sympathetic innervation in the MPTP non-human primate model of Parkinson disease

    Clinical Autonomic Research, Vol. 29, Núm. 4, pp. 415-425

  3. Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers

    Parkinsonism and Related Disorders, Vol. 65, pp. 139-145

2018

  1. Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies

    Acta Neuropathologica, Vol. 135, Núm. 6, pp. 877-886

  2. Mitos y evidencias en el empleo de la toxina botulínica: Neurofarmacología y distonías

    Revista de Neurologia, Vol. 66, Núm. 5, pp. 163-172

2017

  1. Isolated palatal tremor as unique clinical manifestation of SCA 18 due to a new mutation of IFRD1

    Parkinsonism and Related Disorders

2015

  1. Descripción de una serie de pacientes con diagnóstico de enfermedad priónica

    Neurologia, Vol. 30, Núm. 3, pp. 144-152

  2. Perfil neuropsicológico de la degeneración lobar frontotemporal

    Anales del sistema sanitario de Navarra, Vol. 38, Núm. 1, pp. 79-92

2014

  1. Agonistas dopaminérgicos en la enfermedad de Parkinson

    Neurologia

  2. Predictive factors of the response to treatment with onabotulinumtoxina in refractory migraine

    Revista de Neurologia, Vol. 58, Núm. 6, pp. 241-246

  3. Primary Whipple disease of the CNS presenting with chorea and dystonia: A video case report

    Neurology: Clinical Practice, Vol. 4, Núm. 6, pp. 508-510

2013

  1. Is cardiac function impaired in premotor Parkinson's disease? A retrospective cohort study

    Movement Disorders, Vol. 28, Núm. 5, pp. 591-596

  2. Neuroimagen estructural y funcional en las enfermedades priónicas humanas

    Neurologia

2012

  1. Variant Creutzfeldt-Jakob disease occurring in mother and son

    Journal of Neurology, Neurosurgery and Psychiatry